Induction of molecular remission by using anti-CC-chemokine receptor 4 (anti-CCR4) antibodies for adult T cell leukemia: a risk of opportunistic infection after treatment with anti-CCR4 antibodies

収録刊行物

  • Annals of Hematology

    Annals of Hematology 93 (1), 169-171, 2013-04-24

    Springer Science and Business Media LLC

被引用文献 (2)*注記

もっと見る

キーワード

問題の指摘

ページトップへ